Tokyo, Japan

Yasumasa Kato

This inventor holds 20 USPTO granted patents and 10 published patent applications and 5 EPO patents, primarily in Glass Manufacturing. Top assignees: Asahi Glass Company, Limited, Agc Inc., Nireco Corporation. Active years: 2001-2023.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Yasumasa Kato. Retrieved from https://idiyas.com/inventor/yasumasa-kato

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 20 

% Patents Active = 80.0

 

Average Co-Inventor Count = 2.9

ph-index = 5

Forward Citations = 101(Granted Patents)


Location History:

  • Kanagawa, JP (2005)
  • Chiyoda-ku, JP (2013 - 2020)
  • Yokohama, JP (2001 - 2023)
  • Tokyo, JP (2012 - 2023)

Company Filing History:


Years Active: 2001-2023

Loading Chart...
Loading Chart...
Areas of Expertise:
Tempered Glass
Liquid Crystal Display
Alkali-Free Glass
Glass Plate
Glass Substrate
Laminated Glass
Annealing
Distance Measuring
Molten Metal Level
Air-Cooling
Quenching Method
20 patents (USPTO):Explore Patents

Title: Innovator Profile: Yasumasa Kato – A Luminary in Diabetes Treatment and Display Technologies

Introduction: Yasumasa Kato, an accomplished inventor based in Tokyo, Japan, holds an impressive portfolio of 20 patents. His work primarily focuses on innovative treatments for diabetes and advancements in display technology, showcasing his exceptional contributions to the field of science and technology.

Latest Patents: Among Yasumasa Kato's noteworthy inventions are his recent patents that provide groundbreaking solutions for diabetes management. One such patent outlines a method for determining a composition effective for treating diabetes mellitus, emphasizing a treatment that exhibits an excellent hypoglycemic effect. This innovation effectively suppresses lactic acidosis without significantly increasing blood lactate concentration. The composition includes branched-chain amino acids along with salts of biguanide derivatives, ensuring enhanced effectiveness, particularly when incorporating leucine, isoleucine, or valine as branched-chain amino acids, and metformin as the biguanide derivative.

Additionally, Kato has patented a novel liquid crystal display panel, meticulously designed to fulfill specific physical requirements. The panel features a wiring film made of metal, an insulating film with inorganic substances, and a substrate composed of non-alkali glass. This invention is characterized by precise specifications for Young's modulus and thermal expansion coefficients, guaranteeing optimal performance and durability.

Career Highlights: Yasumasa Kato's career is marked by his association with prominent organizations. He has contributed significantly to the Asahi Glass Company, Limited, and AGC Inc., where he played a pivotal role in advancing technologies related to glass and materials science.

Collaborations: Throughout his career, Kato has collaborated with esteemed colleagues, including Kazushige Yoda and Satoshi Yoshida. Their collective expertise in various domains has undoubtedly enriched the innovative output of their projects and contributed to advancements in technology.

Conclusion: Yasumasa Kato exemplifies the spirit of innovation through his prolific patent portfolio and collaborative endeavors. His contributions to diabetes treatment and display technologies not only highlight his ingenuity but also underscore the importance of continuous research and development in driving progress within the scientific community.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…